Added to YB: 2017-06-07
Pitch date: 2017-06-07
ACAD:US [bullish]
ACADIA Pharmaceuticals Inc.
-19.94%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
Market Cap
$3.7B
Pitch Price
$30.39
Price Target
N/A
Dividend
N/A
EV/EBITDA
24.24
P/E
14.29
EV/Sales
2.80
Sector
Biotechnology
Category
N/A
Show full summary:
ACADIA Pharmaceuticals Inc. ACAD:US
A summary for this pitch has not been created yet.
Read full article (0 min)